This event has now passed! But you can access the event highlights ON DEMAND and watch whenever you'd like by filling the form below.
VCCircle Healthcare Investment Summit 2019
As home to one in six persons on the planet, India is not just a land of opportunity for those eyeing its vast consumer class but also a huge captive market for healthcare. The sector comprising hospitals, medicines, devices, diagnostics and new age health-tech businesses is estimated to be growing a tad faster than the nominal growth of the economy and is projected to cross $300 billion by 2022.
Healthcare has been one of the few sectors that has been consistently showing up in the radar of both private investors as well as strategic acquirers. According to VCCEdge, the sector has consistently attracted $1-2 billion of private investment and $3-5 billion of M&As over the last several years.
While healthcare services have pulled in a good chunk of the PE money, drug makers have been the driving force for M&As, especially overseas deals to penetrate deeper into the regulated markets of US and Europe.
With a vast chunk of healthcare services still run by public institutions, the government has also been actively looking to up the game. It launched the world’s largest state funded healthcare scheme under Ayushman Bharat last September. Its think-tank NITI Aayog also came out with a plan to create a national health stack and a national health register that seeks to maintain health records of citizens.
Although the projects face question marks related to data safety these could drive better outcomes for healthcare diagnosis and delivery while at the same time throwing up a new set of business opportunity, especially for tech firms.
On the one hand, this spells big business to be carved out by health entrepreneurs, it also brings major challenges given the widening demand supply gap and skills shortage besides the regulatory issues. In particular, the generics pharma giants have been facing regulatory baton in key overseas markets, the price capping in domestic market also affects the business strategy. Price control moves have also hit the healthcare delivery and medical device sector in the recent past.
To discuss the business opportunity and the emerging challenges, Mosaic Digital, the corporate banner behind VCCircle is organising its next edition of Healthcare Investment Summit on October 11 at Hotel ITC Grand Central in Mumbai.
By Shalil Gupta, CBO, Mosaic Digital
By Umang Vohra, MD & Global CEO, Cipla
The new digital health is focussed on four key elements including disruption, integration, “engagement and trust”. Digital is empowering patients to play a more active role in their own care and making processes more efficient for providers. Traditional delivery processes today, face the risk of being disrupted. How are healthcare providers fulfilling the demands of the new age patient?
Moving health services outside of the hospital and towards patient presence – in other words, enabling a digitalized care continuum will be eminent to combat tech enabled and dynamically disruptive demand drivers. What are the new practices that healthcare providers are adopting?
Shyatto Raha, Founder & CEO, MyHealthcare
Raviganesh Venkataraman, CEO, Cloudnine Group of Hospitals
Dr Harish Pillai, CEO – India, Aster DM Healthcare
Moderator: Sumit Nadgir, MD, True North
10:40 am – 10:50 am
The Decade of Data: Healthcare beyond 2020
By Zoya Brar, Founder and CEO, Core Diagnostics
10:50 am – 11:00 am
Health-tech- what does analytics tell us about customer behaviour
By Gaurav Agarwal, Co - Founder, 1MG
Pharmaceutical companies have made significant progress on their journey towards digital transformation, despite regulatory restrictions. Digital interventions have helped enhance engagement with doctors, thus transforming historical marketing practices. Further, online pharmacies are empowering customers with better prices and options. How are these pharma stakeholders (Pharma companies, e-pharmacies, hospital purchase, etc) working together to enhance cuMadhukar Gangadi, Founder and CEO, MedPlus Health Services
Dr. Madhukar Gangadi, Founder and CEO, MedPlus Health Services
Kedar Rajadnye, CEO, Integrace Health
Ameesh Masurekar, Founder & Director, AIOCD AWACS
Pradyumn Singh, MD & Co- founder, Pharmarack
Moderator: Dr Ramesh B Byrapaneni, MD, Endiya Partners
Venue: Pre-Function Area
12:10 pm – 12:20 pm
Short keynote on How is diagnostics industry evolving? by A Velumani, CEO, Thyrocare
Followed by
12:20 pm – 13:00 pm
Panel Discussion III on Driving efficiencies in diagnostics business?
With the spectre of Essential Diagnostics List and price caps looming over diagnostics industry, margins may come under pressure. What are the ways pathology chains can leverage technology to drive more efficiencies? How can diagnostic companies, doctors and hospitals work together to provide seamless experience to patients?
Ameera Shah, MD, Metropolis Healthcare Ltd.
Arunima Patel, Founder and Managing Director, IGenetic Diagnostics
Dr. VL Ramprasad, CEO, MedGenome Labs
Dr. A Velumani, CEO, Thyrocare
Moderator: Vishal Bali, Executive Chairman, Asia Healthcare Holdings
Large corporate hospital chains have seen a string of consolidation moves and eyes are now on the regional champions. Can the regional chains hold their nerves to expand outside their comfort zones? Would the larger national chains see acquisition of smaller hospital groups as the next growth driver? How do the two sets plan to bridge the rising trust deficit of patients?
Dr. Dinesh Batra, Director & Group CEO, Cygnus Hospitals
Dr Raajiv Singhal, Group CEO, Care Hospitals & MD -Healthcare Ops, Evercare India
Dr Keyur Parikh, Founder & Chairman, Care Institute of Medical Sciences (CIMS) Hospital
Dr. Sheriff M. Sahadulla, CEO, KIMS Healthcare Group
Moderator: Nitish Agrawal, Managing Director, Indium Capital
A curated platform that brings together a set of handpicked innovative healthcare start-ups making an elevator pitch to select jury of angel investors & VCs.
Jury Members:
Prerna Bhutani, Partner, India Quotient
Sunil Thakur, Managing Director, Quadria Capital Advisors Private Limited
Dr Ramesh B Byrapaneni, MD, Endiya Partners
Umang Vohra has been Managing Director and Global Chief Executive Officer (MD & GCEO) of Cipla since September 2016. Umang joined Cipla in October 2015 as its Global Chief Financial Officer, and from January 2016 to August 2016 was Cipla’s Global Chief Operating Officer.
After gaining degrees in engineering, marketing and finance, Umang was associated with companies such as Eicher Motors and PepsiCo. Prior to joining Cipla, Umang was Head of the North America business for Dr. Reddy’s Laboratories. Through his previous roles in India and the USA, he has built a distinguished career spanning almost two decades with deep understanding and experience in various aspects of the global pharmaceutical business.
Under Umang’s leadership, Cipla has built strong momentum in its home markets, augmented its capability, strengthened its core, and shown significant improvement in its operating margin and profitability. At the helm of the Management Council of Cipla, Umang’s big-picture agenda is to define and execute Cipla’s strategic growth roadmap and geographical footprint, identify the next levers of growth, invest in innovation for the future, and build the right organisation. Recognised as an action-oriented industry leader, Umang is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to shaping the healthcare ecosystem and making a difference to the lives of patients.
Gaurav is the co-founder of 1mg, India's #1 Health platform. With over 18 million app downloads, and 160 million monthly Page Views, 1mg is the favorite app for health consumers across the country. Gaurav was born and raised in Kanpur.
He is a Computer Science graduate from Indian Institute of Technology-Delhi (IIT-D). Prior to 1mg, Gaurav was the Business Head at Zynga for its globally bestselling online social gaming business, Farmville.
A doctor with exceptional leadership skills, Dr. Harish Pillai joined the Aster DM Healthcare Group as the CEO of Aster Medcity, Kochi in the year 2013. His ability to strategize and manage large-scale healthcare organisations helped Aster Medcity consolidate its place among the top hospitals in the country in a matter of just one year.
Subsequently, Dr. Harish Pillai was promoted as the Cluster Head of Aster DM Healthcare in Kerala and Hyderabad that included 5 hospitals. He was also responsible for commissioning the upcoming green-field projects of the group. In April 2018, Dr. Harish Pillai was promoted as the CEO of Aster India that is currently spread across 5 states and has 13 hospitals with around 4500 beds and 8 clinics.
An expert in hospital administration, quality, brand management, business strategy, product launches and joint ventures, Dr. Harish Pillai has played a significant role in the development of the healthcare industry in India and the Middle East & North Africa (MENA) by setting new benchmarks in quality and patient care.
Prior to joining Aster DM Healthcare, Dr. Harish Pillai was the CEO of Egypt’s biggest private tertiary care hospital - As Salam International Hospital, Cairo, for over 7 years. He has also been instrumental in implementing several high-value healthcare initiatives in Cairo.
One of the most influential leaders in the Indian healthcare industry, Dr. Harish Pillai is a Member of the Joint Commission International (JCI) Standards Advisory Panel; Member of Governance Council of Association of Healthcare Providers (AHPI); National Co- Chair for Medical Value Travel Committee in Federation of Indian Chambers of Commerce and Industry (FICCI); Elected secretary of the Kerala Medical Value Travel Society (KMVTS); visiting faculty at Tata Institute of Social Sciences (TISS) Mumbai and Administrative Staff College of India (ASCI) Hyderabad.
Dr. Harish Pillai has featured in the April 2018 Cover Story of Healthcare Radius Magazine and was conferred with a Special Jury Award for CEO of The Year at the 1st BW Healthcare Hospital Summit & Awards in May 2019.
For the last 20 years, Ms. Shah has focused on delivering sustained growth, built and led corporate functions, including finance, strategy, business process optimization, innovation, investor relations, etc. Under her leadership, Metropolis raised the bar of diagnostic accuracy, technological equipment, customer experience and research-driven, empathetic service. Ms. Shah has been responsible for corporatizing Metropolis by setting protocols, hiring expert professionals for the management team and bringing together a fully actualized board.
Named amongst ‘Asia’s Most Powerful Women in Business’ by Forbes Asia and ‘Fifty Most Powerful Women in Business’ by Fortune India, Ms. Shah is recognized as a global thought leader in the healthcare industry. She has also played an instrumental role in changing the pathology industry landscape in the country; from being a doctor-led practice to a professional corporate group in an extremely unregulated, competitive and fragmented market.
Ms. Shah received a degree in Finance from The University of Texas at Austin and has also completed the prestigious Owner-President Management Program at Harvard Business School.
Ms Shah is also an active financial investor and business mentor. Passionate about the women leadership and empowerment, she has committed to supporting budding women entrepreneurs. This led her to set up Empoweress, a not-for-profit platform for women-led businesses to find advice, mentorship and micro-funding. Launched in 2017, the platform incubates more than 50 women-led businesses already.
An eminent industry spokesperson, she has been featured as a speaker in various National and International forums, industry events and conclaves organized by IIM, Harvard Business School, TedX, CII, FICCI, Twitter amongst others. She has also been elected the Secretary of the IAPL (Indian Association of Pathology Laboratories) and has served as the Chairperson of the ‘FICCI Health services Western Subgroup’ that drives policy decisions at the Center.
Ms. Shah is an independent director on the board of reputed Indian companies (Kaya, Torrent Pharma, Shoppers Stop) and is also an advisor to Baylor College of Medicine. She is also on the global advisory board of AXA, a Paris headquartered company with 700 Billion $ under asset management.
Notable Awards and Accolades
Raviganesh Venkataraman is the Chief Operating officer for Cloudnine Group of Hospitals currently based in Bengaluru. Prior to joining Cloudnine Group, he has held several executive positions handling diverse roles in operations, procurement and sales with several large corporates. During his previous stint with Metro Cash and Carry India Private Limited, he was in charge of procurement, merchandising and supply chain for the Indian operations in capacity of its Director- Offer Management & supply chain.
As the Chief Operating Officer, he is responsible for driving and overseeing the continuous renewal of key processes, business developments, M& A, systems and policies across the company in doctor and customer relationship management, sales effectiveness, delivery excellence, quality, talent management and leadership development. With more than XX years of experience, Raviganesh started his career with Godrej & Boyce Mfg. Co and later worked with Titan Industries, Coco Cola, Subhiksha, Bharti Airtel in the past.
As a production engineer from KJ Somaiya College of Engineering, Mumbai, Raviganesh also holds a Masters in Operations Management Studies from SP Jain Institute of Management and Research, Mumbai.
Satish joined True North in 2005 and is based in Bengaluru. He joined the firm as part of the business management team and worked with companies across healthcare, media, retail and industrials. He is now part of the investment team and is responsible for investments in healthcare sector.
He holds a Mechanical Engineering degree from the IIT, Chennai and a Post Graduate Diploma in Management from the IIM, Kolkata. Prior to joining True North, Satish had six years of experience working with Tata Motors, Accenture and JP Morgan in India.
Shyatto’s experience in business strategy spans the Indian Sub-Continent, South East Asia and the Middle East. He has worked with organisations such as the NDTV Group, Astro Networks (Malaysia and Indonesia). He was responsible for setting up and managing the operations of NDTV’s news network (STAR News, NDTV 24x7, NDTV India and NDTV Profit).
Over the past 3 years, as founder, Shyatto has focussed on building MyHealthcare. MyHealthcare is a digital healthcare ecosystem that enhances patient engagement and empowers them with their healthcare needs, through offerings such as EHR, health trackers, emergency services, video consult, 24x7 health monitoring, etc. The platform helps connect healthcare givers, hospitals, diagnostics, patients and their family and brings them into a digital ecosystem. MyHealthcare has at its core a HIPAA compliant MyHealthcare SPINE that connects with HIS and offers a user-friendly patient app, a doctor app, a paramedic app, a customer website widget and an internal hospital portal (a patient support platform for the hospital team). The platform is offered in a partnership model with hospitals and healthcare institutions.
Shyatto is an alumnus of the Harvard Business School and a member of the Harvard Angels Network (India).
Sumit joined True North in 2016 and is based out of Mumbai. He is closely involved in supporting and building True North companies across different sectors including healthcare, consumer goods, industrial services, etc. He is a Mechanical Engineer from Pune and has a Post Graduate Diploma from Indian Institute of Management, Kolkata.
Prior to joining True North, Sumit was a Principal with Bain & Co. where he supported several domestic & multinational firms across sectors including industrial goods & services, textiles, chemicals, infrastructure, health care, consumer goods dealing with growth strategies, operational efficiency, cost reduction, organization effectiveness, etc. Before Bain, he helped set up an engine manufacturing plant for the Kirloskar Group and implement lean systems across their operations. Earlier, he worked with J&J Medical, where he managed the sales of cardiac devices.
Indium is a healthcare focused investment banking advisory firm. Based in Bengaluru, Nitish has advised on domestic and cross border M&A as well as equity fund raising transactions across all segments of healthcare including large hospital chains, single speciality formats (maternity, IVF, etc), diagnostics, medical devices, and healthcare-tech with a cumulative experience of evaluating over 45+ deals in healthcare.
Nitish has had over 18 years of leadership experience in the past across Allegro Capital, GE Capital & Genpact. He is an engineer from IIT, BHU and holds a Post Graduate Diploma in Management from IIM Calcutta.
A visionary and an able business administrator, Dr. A. Velumani proves amply clearly to industry that, “Focus gives Success”. Born toa landless farmer in a small village near Coimbatore, South India, today he owns and operates Thyrocare, an industry leader and a brand worth over Rs. 3000 crores. Began as a mathematician, he acquired his Ph.D in Thyroid Biochemistry from BARC / Mumbai University. He worked for 14 years in BARC as a Research Scientist and Teacher and then became an administrator in business.
He is also MD of Nueclear Healthcare Limited which is a Radiology vertical. His focus areas are Thyroid Biochemistry, Bioanalytical Chemistry, Nuclear Chemistry and Nuclear Medicine.
An infectious motivator, he has succeeded in converting educated as employed, graduates as professionals, individuals as entrepreneurs, vendors as partners, family members as wealth creators and by his unique way, transformed intimidating problems into opportunities.
He is hilarious when it comes to educating and motivating youth in Entrepreneurship.
After completing her engineering degree in Electronics & Communications, Ms. Patel did MBA from Indian Institute of Management, Ahmedabad (IIMA).
She started her career with multinationals like Prudential Insurance and IBM. She then joined the healthcare investment team of private equity firm Actis where she was instrumental in Actis’s investment into Sterling Hospitals.
It was her stint at Actis that she realized the need and scope of molecular testing service, an activity that were at nascent stages in India then.
She then started iGenetic from scratch with a committed to provide quality diagnostics in Tier II and III cities and rural areas at affordable prices. She was instrumental in attracting investment from marquee investors such as Manipal Education & Medical Group and CDC which is UK Government’s private equity arm. Before MEMG and CDC, she raised Rs 6.5 crore from high net worth individuals.
Ms. Patel has been rightly selected by Forbes India to be one of the women power trailblazers for the year 2018.
In Near future, she plans to take iGenetic to greater heights and the company will continue setting new benchmarks in diagnosis of serious issues such as critical care infections, cancer, infertility, neurology and others. iGenetic is already earned the stature of being the only diagnostics company in India to that can deliver a septicemia (infection of the blood) test report within 24 hours. With a mission to touch a billion lives through the services of her company, Ms. Patel plans to take iGenetic’s presence to Sri Lanka, Middle East and other neighboring countries.
She is socially inclined and is personally contributing to several NGOs. Education in the country and skills are areas dear to her and she is involved with two foundations – Skills Foundation which is building and managing schools for remote areas in Bihar and Adharshilla which funds and manages schools in Madhya Pradesh.
When she is not working, she is globe-trotting being an avid traveler. She is also passionate about health and runs and cycles every day in her free time.
Zoya Brar founded CORE Diagnostics, a high-end clinical laboratory, focused on brining innovation to the diagnostic industry in 2012 when she was 23 years old.
Having been brought up in Chandigarh, Ludhiana and Delhi in her early years and her teens by a single mother who was herself a successful healthcare executive, Zoya, in her own words “…. learned about leadership through osmosis,” and honed her leadership skills in various roles while writing for the Youth Parliament, organizing street plays, working for Parivartan an NGO aimed at helping people with disabilities, working directly for the Chairman at the WLC group, as well at the Debating Society and several such initiatives while in school.
Zoya got a bachelor’s degree in Sociology at Lady Shri Ram College. She then worked at Google for 2 years before succumbing to the entrepreneurship bug. She founded CORE, raised INR 25 Crore in initial funding from the Silicon Valley based Artiman Ventures, and in a little over 3 years, has established CORE to be synonymous with innovation in Clinical Diagnostics. Meanwhile, the business has grown nearly 10% every month and has attracted an additional INR 25 Crore in funding.
Zoya is an avid reader of prose and poetry. She writes an occasional blog, and is writing her first book - a work of fiction.
Zoya has spoken at a number of prestigious events including the Medtech Women conference in California, FICC, Heal at Delhi, VCCircle at Bangalore. She has also been featured on a number of television shows including Awaaz Enterpreuneur on CNBC and The Big Idea on Zee News.
Dr. Ramesh Byrapaneni, MD, Endiya Partners, is a cardiologist who turned into a venture capitalist, to be a part of the healthcare innovation story. At Endiya, Dr. Ramesh has led our investments in Healthtech companies- SigTuple, ekincare and cure.fit.
Prior to Endiya, at Ventureast, he invested in companies like OneBreath and SmartRx . Dr. Ramesh is also an angel investor with Nephroplus, India’s largest chain of dialysis clinics. Earlier, Dr. Ramesh was Chief of Cardiology and Founder of Medwin Hospital. He is also the Founding Director of Hyderabad Angels and has been President of TiE Hyderabad for four years.
A well-known healthcare management expert with over 30 years of experience in the healthcare industry in India and other countries. Over last 3 decades, Dr. Batra has worked across various healthcare brands with the latest being Primus Super specialty hospital in Chanakyapuri in Delhi as the CEO. He was one of the key players in the success story of the Primus Group.
He then began the journey of Cygnus Hospitals with four more doctors and a pharma entrepreneur. Dr. Batra is aggressively involved in administration, planning and development of the eleven hospitals, currently under Cygnus Group. He has actively participated in healthcare projects for tribal areas, for patients needing free dialysis, and free education to under-privileged. Dr. Batra is associated with many leading healthcare institutes in Delhi NCR as a Medical Advisor.
In 2015, Dr. Batra, was invited by Government of Haryana in association with CII to a ‘Business Mission to US & Canada’. The prime objective of this mission was to reposition Haryana as an investment destination on the International stage with a focus on the sector like – Energy, Aerospace, Defence production including offset Manufacturing, Garments / Textiles, Food Processing, Auto/Auto Components, Healthcare, Industrial Parks, Logistics, mass rapid transport as also to seek cooperation in the field of Education/Skill development.
A Graduate and Post Graduate of the prestigious Armed Forces Medical College (AFMC), Pune and an alumnus of IIM, Ahmedabad, I have extensive experience of over 25 years in the healthcare industry. I have played an instrumental role in setting-up the first e-ICU concept in India and have established Hub and Spoke model for several successful Heart Command Centers in India and abroad including UAE, Nepal, Bangladesh, and Afghanistan.
I also serve as visiting faculty for management programs at prestigious institutes like AIIMS, AFMC, and Symbiosis University of Health Sciences. I am actively associated with various Healthcare Committees such as FICCI and served as Co-Chair of the FICCI Committee on Health Insurance and member of FICCI Health Services National Committee. I was also felicitated by Governor of Karnataka for outstanding contribution for ‘Innovation in Healthcare’.
As Group CEO of CARE Hospitals, I was entrusted with the responsibility to turn around CARE group of hospitals with over 2000 beds across 12 hospitals in November 2017. Created the biggest group turnaround in Indian healthcare as Group CEO amidst harsh realities of difficult financial circumstances and severe external and internal pressures.
Conferred with “Economic times healthcare business leader award for 2018-19”
Past:
Started MedPlus in 2005 executing on a business plan written in his final semester at B-school. MedPlus under his leadership has grown to be the second largest retail chain in the country with over 1700 stores across 7 states in the country.
Dr. Gangadi has an MBBS from Kurnool Medical College and an MBA from the Wharton School of Business.
Dr. Vedam Ramprasad is a scientist with several peer-reviewed publications to his credit. He believes in harnessing the power of genomics for providing better outlook to patients. He has been with MedGenome since its inception and spearheads operations and strategy. He has been a prime driver in building the diverse genetic testing portfolio MedGenome offers.
He is also credited for launching some of the critical genetic tests at affordable price which include the Non-Invasive Pre-natal test (NIPT), Carrier screening test, and Liquid Biopsy to name a few. His commitment to adhere to the highest quality standards and processes has been instrumental in obtaining CAP accreditation for MedGenome. With over a two decade of experience, Dr. Ramprasad was previously associated with Vision Research Foundation, Sankara Nethralaya, Spinco Biotech and SciGenom labs. He holds a Master’s degree and a PhD from BITS, Pilani.
Vishal Bali brings with him 28 years of experience in building and leading global healthcare delivery organizations across developed and developing countries through a combination of organic and M&A driven strategic growth. Vishal brings with him a unique and diversified business experience of managing a $ 1bn P&L of an integrated healthcare delivery organisation comprising a wide spectrum of healthcare verticals including Hospitals, Diagnostics, Primary Care and Daycare Speciality networks across Asia Pacific. Having worked with a highly talented and multi cultural global team based in Singapore, Australia, India, Hong Kong, Vietnam, Srilanka, Dubai and multiple other countries has given him the exceptional opportunity to grow teams and transform healthcare businesses across geographies.
Vishal is currently Executive Chairman, Asia Healthcare Holdings and Senior Advisor, TPG Growth. He is also Co-founder of Medwell Ventures.
Asia Healthcare Holdings is the single speciality healthcare delivery platform backed by TPG Growth which has built India’s second largest Oncology hospitals chain and the largest Mother & Child network in the country. Prior to his current assignment Vishal was the Group CEO for Fortis Healthcare Limited, India’s second largest healthcare delivery enterprise with a network of 68 hospitals and a pan India pathology diagnostics chain. He led Fortis Healthcare’s foray to build Asia's leading integrated healthcare delivery system with a presence across 12 countries and a human capital base of more than 20000 people. One of his key contributions in the Indian healthcare ecosystem includes spearheading the growth and transformation of Wockhardt Hospitals from a single hospital to one of the largest pan India speciality hospital chains as its CEO & Managing Director. He led India’s largest healthcare delivery merger of Wockhardt Hospitals with Fortis Healthcare. Vishal’s expertise in healthcare M&A, post merger integration and divestments has given him a unique perspective on the rapidly evolving healthcare sector of Asia Pacific. He completed his Bachelors in Science and Post graduation in Business from Bombay University and completed an advance program in hospital management from Harvard Medical, Boston. He sits on the board of leading healthcare organisations and has been an invited member of the Strategic Initiatives group of Joint Commission International, US and a past member of the Global Agenda Healthcare Council of the World Economic Forum. His keen interest in education and globalisation of healthcare takes him to leading Healthcare Education Institutes and Business Schools globally which include case studies at the Harvard Business School. He is an active member of various Industry bodies and globally recognized industry public speaker.
Chairman, CIMS Hospital. One of the senior-most Interventional Cardiologists of India associated with pioneering invasive and interventional cardiology work in India, triple diplomats of Board of Internal Medicine, Cardiology & Interventional Cardiology (having lived in USA from 1982-1995). An alumnus of the Harvard Business School, Owner/President Management (OPM Program-48) in 2014-2016.
Awards & accomplishments:
Kedar Rajadnye is the Chief Executive Officer at Integrace and a member of the Executive Committee. He comes with more than 21 years of experience and has worked with Piramal Healthcare India Ltd, where he was the COO of the consumer products business.
Kedar's entrepreneurial and strategic ability has seen him successfully lead different businesses within the Piramal Healthcare group for the last 14 years. Prior to Piramal, he has worked with the FMCG giant Hindustan Unilever. Kedar is an accomplished leader, with a track record of working with high-growth Pharma and FMCG companies. He brings a great mix of leadership, inspiration, operational experience, technical breadth, and passion for people development.
Kedar Rajadnye is the Chief Executive Officer at Integrace and a member of the Executive Committee. He comes with more than 21 years of experience and has worked with Piramal Healthcare India Ltd, where he was the COO of the consumer products business.
Kedar's entrepreneurial and strategic ability has seen him successfully lead different businesses within the Piramal Healthcare group for the last 14 years. Prior to Piramal, he has worked with the FMCG giant Hindustan Unilever. Kedar is an accomplished leader, with a track record of working with high-growth Pharma and FMCG companies. He brings a great mix of leadership, inspiration, operational experience, technical breadth, and passion for people development.
Ameesh Masurekar is Director – AIOCD AWACS – which is into Pharma Market Research & IT Infrastructure in Pharma Channel. He started his career as a Medical Rep with Eli Lilly and was into Brand Management in Nicholas Piramal. In his 2 decade-plus career, data always excites him and the enormous opportunities to use data keeps driving him!
Pradyumn Singh is the Co-founder & MD of Pharmarack Technologies a healthtech startup focusing on e-distribution, supply chain efficiencies, big data analytics driven through AI and machine learning technologies. A chemical engineer by education, He is an ardent believer in progressive business disruption through big data and insight mining.
With over 15 yrs of experience across various functions like Business lead, Marketing, Structuring, Strategy & operations in Debt market & Asset management sector, Pradyumn is a problem solver.
Pradyumn founded Pharmarack and built its core team. He spearheads sales, business operations besides guiding overall product development and creating long lasting relations with the network.
Dr. Ramesh Byrapaneni, MD, Endiya Partners, is a cardiologist who turned into a venture capitalist, to be a part of the healthcare innovation story. At Endiya, Dr. Ramesh has led our investments in Healthtech companies- SigTuple, ekincare and cure.fit.
Prior to Endiya, at Ventureast, he invested in companies like OneBreath and SmartRx . Dr. Ramesh is also an angel investor with Nephroplus, India’s largest chain of dialysis clinics. Earlier, Dr. Ramesh was Chief of Cardiology and Founder of Medwin Hospital. He is also the Founding Director of Hyderabad Angels and has been President of TiE Hyderabad for four years.
Sunil has an extensive healthcare investment and transaction experience across the Asia-Pacific market and has been involved in some of the landmark deals in the healthcare space. In his career spanning 18+ years, Sunil has led and executed deals worth over US$ 7 billion across M&A and Capital Raise.
He serves on the board and committees of various healthcare companies and few prestigious institutions. He is a governing council member of NATHEALTH and a member on CII – National Committee on Biotechnology.
Prior to Quadria Capital, Sunil has worked with Religare Capital Markets and PNB Gilts at various senior positions. He has a Masters Degree in International Business from Delhi School of Economics.
True North traces its origins back to 1999, when it was originally named India Value Fund. Today is one of India’s leading home grown private equity funds, founded with a focus on investing in and transforming mid-sized profitable businesses into world-class industry leaders, built on the strong foundation of True North Values which are embodied within the principles of ‘The Right Way’.
True North has built deep knowledge and skills in the Indian markets and has successfully launched six separate investment funds with a combined corpus of over US$ 2.8 billion including co-investments. True North’s insights and understanding of India has been sharpened over the last two decades by investing in more than 40 Indian businesses. It has successfully guided these companies in making the transition into well-established and large businesses that are valuable, enduring and socially responsible.
The company has significant focus on and extensive experience of evaluating and investing in multiple businesses across a range of segments in the Indian healthcare sector having invested over US$ 520 million across 10 companies.
The True North team has been structured with a balanced mix of 13 Investment Managers and 18 Business Managers, who bring with them several hundred man-years of industry experience.
Indium Capital is an Investment Bank focusing on Fund-Raising, Mergers & Acquisitions and Growth Strategy Advisory. We provide end-to-end services across our focus sectors: Healthcare, Consumer Brands & Technology. Indium has had significant depth of experience in these sectors, with expertise across all segments of Healthcare Delivery (hospitals, medical devices, diagnostics chains and single speciality centers), Consumer Brands (apparel, accessories, foods and other retail brands) & Technology (edu-tech, fin-tech, health-tech, etc.).
The Indium team comes from a diverse background with experience across Corporate Finance, Business Consulting & Strategy; and in the past have advised on multiple M&A and Fundraising transactions with total transaction value of over US$ 3 billion.
VCC Events opens up the avenues for participation. Join hands to be a part of India’s largest gathering of alternative investments leaders, industry stakeholders and Asia’s influential limited partners, general partners and marquee advisors. Your chance to actively participate and augment yourself as thought leaders.
ITC Grand Central Hotel, Mumbai
Date: 11 October, 2019
Drop us a line and we will call you.
